Clinical Trial Update: Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly

View source ↗

Summary

Completed clinical trial evaluating the safety of three formulations of Ketasyn given for 14 days in healthy elderly participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Ketasyn

Snippet

Sponsor: Cerecin | Conditions: Alzheimer's Disease | Status: COMPLETED